MLL 2.0 – From See Behind to Go Beyond
Dr. Claudia Haferlach covers and explains the transformative role of technologic advancements, including artificial intelligence (AI) in hematology, particularly in leukemia diagnostics with emphasis on the use of AI-driven diagnostic techniques to improve the accuracy and efficiency of cytomorphology and karyotyping.
Originally published on May 22, 2024
Lecture Presenter
Professor Claudia Haferlach, MD
Executive Management, Medical Doctor, Department Manager of Diagnostics
Munich Leukemia Laboratories
Professor Claudia Haferlach is an internationally renowned geneticist with extensive research experience in leukemia diagnostics and genomics. Her research focuses on identifying genetic alterations associated with leukemia. She has authored or co-authored hundreds of research publications demonstrating her significant contributions to the field of leukemia research.
Sponsored by:
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories